Document is current

Article History

Accepted: 17 August 2023

First Online: 12 September 2023

Compliance with Ethical Standards

:

: Dr. Oliveros has a research grant from Johnson and Johnson. Dr. Saldarriaga Giraldo is a speaker for Novartis, Pfizer, Servier, AstraZeneca, Medtronic, Abbot, Bayer, and Boehringer Ingelheim; advisor for Bayer, Servier, and AstraZeneca; and principal investigator in clinical trials for Merck, Amgen, Bayer, and Novartis. Elizabeth Tinuoye has no conflict of interest of financial disclosures to submit. Dr. Rodriguez Gonzalez is a speaker for Novartis, Pfizer, AstraZeneca, Abbot, Bayer, and Boehringer Ingelheim; advisor for Boehringer Ingelheim, Novartis, and AstraZeneca and principal investigator in clinical trials for Novartis and has grants in progress from Pfizer. Dr. Gallego is a speaker for Novartis, Pfizer, AstraZeneca, AbbVie, and Boehringer Ingelheim; advisor for Pfizer; and principal investigator for Bayer. Dr. Contreras is an advisor for Novo Nordisk, Merck, AstraZeneca, and Alnylam and principal investigator and has grants from AstraZeneca and Novo Nordisk.

: This article does not contain any studies with human or animal subjects performed by any of the authors.